Polypharmacy: A Continuing Challenge to Clinicians.

Clin Geriatr Med

David Geffen School of Medicine at UCLA, 200 UCLA Medical Plaza, Suite 420, Los Angeles, CA 90095, USA. Electronic address:

Published: November 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759697PMC
http://dx.doi.org/10.1016/j.cger.2022.07.010DOI Listing

Publication Analysis

Top Keywords

polypharmacy continuing
4
continuing challenge
4
challenge clinicians
4
polypharmacy
1
challenge
1
clinicians
1

Similar Publications

Background: Prescription auditing is a crucial tool for evaluating a range of concerns, including injectable usage, polypharmacy, the use of generic names, and the quality of treatment given to patients in primary care facilities. The objective of the study was to assess, using WHO core drug use indicators, the drug use patterns of general outpatients (OPD) at a rural healthcare facility.

Materials And Methods: A cross-sectional study was conducted in a rural peripheral health centre in Puducherry for a period of one year from September 2019 to August 2020.

View Article and Find Full Text PDF

Background: Ventilator-associated pneumonia (VAP) is a prevalent nosocomial infection in the intensive care unit (ICU), significantly increasing patient morbidity, mortality, and healthcare costs. Effective management is essential, particularly in the context of antimicrobial resistance and the frequent use of antibiotics in ICUs.

Methods: This prospective pre-post interventional study was conducted in the medical ICU of a tertiary care centre, over 6 months.

View Article and Find Full Text PDF

Clozapine treatment continues to be recognized as the gold standard for managing treatment-resistant schizophrenia. Combining clozapine with other antipsychotics (i.e.

View Article and Find Full Text PDF

Background: Optimal heart failure (HF) pharmacotherapy (guideline-directed medical therapy and diuretics) in older people with frailty is uncertain due to limited evidence.

Aims: To evaluate utilisation of HF pharmacotherapy and prevalence of polypharmacy, adverse drug events (ADEs), falls, delirium, renal impairment and duration of hospitalisation in older inpatients, according to frailty.

Methods: A retrospective cross-sectional study of the TO HOME cohort of 2000 inpatients ≥75 years admitted for ≥48 h to rehabilitation, geriatric or general medicine from 1 July 2016 to 30 June 2017 across six hospitals in Sydney, Australia.

View Article and Find Full Text PDF

Barriers and facilitators to implementing polypharmacy management frameworks: a theory based qualitative exploration of key stakeholders.

Int J Clin Pharm

December 2024

School of Pharmacy and Life Sciences, Applied Sciences and Public Health, Robert Gordon University, Garthdee Road, Aberdeen, AB10 7GJ, UK.

Background: Inappropriate polypharmacy arises through many factors including deficiencies in prescribing processes. Most research has focused on solutions at the clinician/patient levels with less at the organisational level.

Aim: To explore key stakeholder identified barriers and facilitators to implementation of an organisational level polypharmacy management framework.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!